Discuss This Drug

Anti-thymocyte Globulin (Rabbit)

CHEBI:CHEBI_756610

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
107050
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
active_ingredient_strength
5 mg/mL
route
INTRAVENOUS
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
marketing_category
BLA
pharm_class
Antibody-Surface Protein Interactions [MoA]
pharm_class_cs
Immunoglobulins [CS]
marketing_start_date
19981230
package_marketing_start_date
19981230
labeler_name
Genzyme Corporation
manufacturer_name
Genzyme Corporation
nui
N0000020023
pharm_class_epc
Immunoglobulin G [EPC]
pharm_class_pe
Increased T Lymphocyte Destruction [PE]
pharm_class_moa
Antibody-Surface Protein Interactions [MoA]
generic_name
Anti-thymocyte Globulin (Rabbit)
brand_name
Thymoglobulin
brand_name_base
Thymoglobulin
product_ndc
58468-0080
application_number
BLA103869
spl_id
dbf56743-5065-49cd-b7b4-c91af66b0bb8
active_ingredient_name
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN
package_ndc
58468-0080-1
package_description
1 VIAL, GLASS in 1 CARTON (58468-0080-1) / 5 mL in 1 VIAL, GLASS
unii
D7RD81HE4W
spl_set_id
bbd8ab99-552e-4b81-aca4-6b0c7af8b9ae
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class